FDA Approves New Eye Drops: Glasses are no less than a boon for those with weak eyesight. At the same time, sometimes it also has to face difficulties. An eye drop has been approved in the US, which is claimed to get rid of spectacles by inserting them.

America FDA Approves New Eye Drops: Glasses are undoubtedly a boon for people with weak eyes. With this you can see the things around you, you can study. Glasses have proved to be a boon for those with weak eyesight, but sometimes it also becomes a problem. It is difficult to wear glasses due to excessive sweating. Many people forget them in the house or car while going from home to the office in a hurry. They break easily. In such a situation, an eye drop has been invented to give relief from medical science glasses. It is being claimed that its use can get rid of glasses. This eye drop has been approved in the US.

Problem with mask

Masks have become an important part of our lives since the Covid pandemic. However, wearing a mask is the biggest problem for those wearing glasses. In such a situation, the United States Food and Drug Administration (FDA) has recently approved an eye drop, which can replace glasses.

Medicine has to be put every 6 hours

This drug is named Vuity. It is being claimed that after putting it in the eyes, eyesight can improve. According to a report in Express.co.uk, the eye drops need to be inserted once every six hours and start working within 15 minutes.

Enhances eyesight

According to the report, a drug is a ready-made form of the well-known compound known as pilocarpine and the researchers developed it to quickly optimize the pH of the tear film. Using the eye's natural ability to constrict the pupil, the drop maintains distant vision, while simultaneously enhancing near vision.

Test is done on 750 participants

This drug was tested on 750 participants. According to the analysis of the researchers, the drop is most effective for people in the age group of 40 to 55 years. It does not have any side effects on the eyes. However, some patients reported a slight headache and red eyes.